Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01298765 · ClinicalTrials.gov registry record · Phase 3
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A Phase 3 study, sponsored by BioDelivery Sciences International.
- Completed
- Registry status
- Phase 3
- Development phase
- 302
- Enrollment target
NCT01298765 is a Phase 3 study that has completed, run by BioDelivery Sciences International. The registered enrollment target is 302 participants.
The verdict
NCT01298765, a Phase 3 study, has completed, sponsored by BioDelivery Sciences International.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 302 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether BEMA Buprenorphine is safe in the treatment of chronic pain.
Interventions
- DRUG BEMA Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01298765
The ClinicalTrials.gov registry entry for NCT01298765 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 302 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioDelivery Sciences International, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BEMA Buprenorphine is the first listed.
NCT01298765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01298765 about?
NCT01298765 is a clinical study titled "Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain". The purpose of this study is to determine whether BEMA Buprenorphine is safe in the treatment of chronic pain.
What is the current status of trial NCT01298765?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 302 participants. The study started on 2011-03. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01298765?
The interventions under investigation include: BEMA Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT01298765?
This trial is sponsored by BioDelivery Sciences International, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.